Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
Drug delivery to the central nervous system (CNS) remains a challenge in neuro-oncology. Despite decades of research in this field, no consensus has emerged as to the best approach to tackle this physiological limitation. Moreover, the relevance of doing so is still sometimes questioned in the commu...
Saved in:
Main Author: | David Fortin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lomustine's nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment
by: Maryam H. Alaayedi, et al.
Published: (2023) -
Nose to brain delivery of drugs for CNS diseases
by: Zahraa Ali, et al.
Published: (2021) -
Helping teachers to teach Global Health in health professional educational programs: the Sherbrooke experience
by: C. Valois, et al.
Published: (2017) -
Overcoming the Blood-Brain Barrier. Challenges and Tricks for CNS Drug Delivery
by: Luca Anna Bors, et al.
Published: (2019) -
Results of a feasibility study: barriers and facilitators in implementing the Sherbrooke model in France
by: Jean-Baptiste Fassier, et al.
Published: (2015)